Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BBNX Beta Bionics	$11.05 +0.5%	$13.66	$8.89 ▼ $24.50	$479.01M	N/A	479,145 shs	305,259 shs
KIDS OrthoPediatrics	$20.82 -3.4%	$23.32	$20.25 ▼ $35.99	$505.66M	1.17	198,401 shs	91,445 shs
PROF Profound Medical	$4.99 +2.0%	$5.88	$3.90 ▼ $11.42	$149.96M	0.68	58,762 shs	98,997 shs
TMCI Treace Medical Concepts	$7.08 +0.4%	$7.85	$3.92 ▼ $11.33	$443.37M	0.77	751,068 shs	557,308 shs

Free Today: Your Guide to Smarter Options Trades

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BBNX Beta Bionics	+1.76%	+5.77%	-6.15%	+1,098,999,900.00%	+1,098,999,900.00%
KIDS OrthoPediatrics	-1.01%	+3.81%	-12.89%	-13.24%	-26.27%
PROF Profound Medical	+3.16%	+4.71%	-19.17%	-21.76%	-36.49%
TMCI Treace Medical Concepts	+2.17%	+12.62%	-16.57%	-32.34%	-33.80%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BBNX Beta Bionics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	4.1805 of 5 stars	3.4	1.0	0.0	3.9	3.2	4.2	0.6
PROF Profound Medical	2.2427 of 5 stars	3.7	3.0	0.0	0.0	1.8	0.8	0.6
TMCI Treace Medical Concepts	2.6111 of 5 stars	3.1	2.0	0.0	0.0	2.3	4.2	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BBNX Beta Bionics	2.78	Moderate Buy	$24.83	124.74% Upside
KIDS OrthoPediatrics	2.80	Moderate Buy	$37.00	77.71% Upside
PROF Profound Medical	3.33	Buy	$11.50	130.46% Upside
TMCI Treace Medical Concepts	2.29	Hold	$9.93	40.23% Upside

Current Analyst Ratings Breakdown

Latest PROF, KIDS, BBNX, and TMCI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/23/2025	PROF Profound Medical	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$17.00 ➝ $11.00
4/11/2025	KIDS OrthoPediatrics	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$26.00 ➝ $24.00
4/11/2025	TMCI Treace Medical Concepts	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$9.50 ➝ $8.00
4/9/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00
4/7/2025	KIDS OrthoPediatrics	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$37.00
3/13/2025	TMCI Treace Medical Concepts	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$10.00 ➝ $9.50
3/5/2025	KIDS OrthoPediatrics	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$40.00 ➝ $32.00
3/5/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00
3/3/2025	TMCI Treace Medical Concepts	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$8.40 ➝ $10.00
2/24/2025	BBNX Beta Bionics	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
2/24/2025	BBNX Beta Bionics	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy

(Data available from 4/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BBNX Beta Bionics	$65.12M	7.36	N/A	N/A	N/A	∞
KIDS OrthoPediatrics	$204.73M	2.47	N/A	N/A	$16.14 per share	1.29
PROF Profound Medical	$10.68M	14.04	N/A	N/A	$1.28 per share	3.90
TMCI Treace Medical Concepts	$209.36M	2.13	N/A	N/A	$2.24 per share	3.16

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BBNX Beta Bionics	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	-$20.97M	-$1.63	N/A	N/A	N/A	-15.00%	-5.78%	-4.80%	5/7/2025 (Estimated)
PROF Profound Medical	-$28.57M	-$1.12	N/A	N/A	N/A	-349.41%	-85.22%	-64.87%	5/8/2025 (Estimated)
TMCI Treace Medical Concepts	-$49.53M	-$0.90	N/A	N/A	N/A	-30.33%	-51.12%	-26.36%	5/8/2025 (Estimated)

Latest PROF, KIDS, BBNX, and TMCI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/8/2025	Q1 2025	PROF Profound Medical	-$0.29	N/A	N/A	N/A	$4.78 million	N/A
5/8/2025	Q1 2025	TMCI Treace Medical Concepts	-$0.31	N/A	N/A	N/A	$52.07 million	N/A
5/7/2025	Q1 2025	KIDS OrthoPediatrics	-$0.38	N/A	N/A	N/A	$51.68 million	N/A
3/25/2025	Q4 2024	BBNX Beta Bionics	-$0.42	-$1.82	-$1.40	-$2.72	$20.01 million	$20.44 million
3/6/2025	Q4 2024	PROF Profound Medical	-$0.31	-$0.20	+$0.11	-$0.20	$5.92 million	$4.18 million
3/4/2025	Q4 2024	KIDS OrthoPediatrics	-$0.33	-$0.29	+$0.04	-$0.69	$51.16 million	$52.67 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BBNX Beta Bionics	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	N/A	N/A	N/A	N/A	N/A
PROF Profound Medical	N/A	N/A	N/A	N/A	N/A
TMCI Treace Medical Concepts	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BBNX Beta Bionics	N/A	N/A	N/A
KIDS OrthoPediatrics	0.19	7.17	3.68
PROF Profound Medical	0.11	6.12	5.16
TMCI Treace Medical Concepts	0.51	4.12	2.98

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BBNX Beta Bionics	N/A
KIDS OrthoPediatrics	69.05%
PROF Profound Medical	47.86%
TMCI Treace Medical Concepts	84.08%

Insider Ownership

Company	Insider Ownership
BBNX Beta Bionics	N/A
KIDS OrthoPediatrics	31.80%
PROF Profound Medical	1.52%
TMCI Treace Medical Concepts	27.72%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BBNX Beta Bionics	294	43.35 million	N/A	N/A
KIDS OrthoPediatrics	200	24.29 million	16.52 million	Optionable
PROF Profound Medical	150	30.05 million	29.58 million	Optionable
TMCI Treace Medical Concepts	250	62.89 million	47.08 million	Optionable

PROF, KIDS, BBNX, and TMCI Headlines

Recent News About These Companies

Contact Levi & Korsinsky by June 10, 2025 Deadline to Join Class Action Against Treace Medical Concepts, Inc. (TMCI)

April 30 at 6:45 PM | accessnewswire.com

ROSEN, LEADING INVESTOR COUNSEL, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TMCI

April 30 at 6:30 PM | accessnewswire.com

Class Action Filed Against Treace Medical Concepts, Inc. (TMCI) - June 10, 2025 Deadline to Join - Contact Levi & Korsinsky

April 30 at 4:45 PM | accessnewswire.com

TMCI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Treace Medical Concepts, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

April 30 at 4:00 PM | globenewswire.com

Levi & Korsinsky Notifies Shareholders of Treace Medical Concepts, Inc. (TMCI) of a Class Action Lawsuit and an Upcoming Deadline

April 30 at 3:30 PM | accessnewswire.com

Long-Term Treace Medical Concepts, Inc. (NASDAQ: ™CI) Shareholder Notice: Grabar Law Office Investigates Claims on Your Behalf

April 30 at 1:43 PM | investing.com

Treace Medical Concepts, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before June 10, 2025 to Discuss Your Rights - TMCI

April 30 at 1:30 PM | accessnewswire.com

Shareholders of Treace Medical Concepts, Inc. Should Contact Levi & Korsinsky Before June 10, 2025 to Discuss Your Rights - TMCI

April 30 at 12:15 PM | accessnewswire.com

Treace Medical Concepts, Inc. (TMCI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

April 30 at 12:00 PM | prnewswire.com

Levi & Korsinsky Notifies Shareholders of Treace Medical Concepts, Inc. (TMCI) of a Class Action Lawsuit and an Upcoming Deadline

April 30 at 11:00 AM | accessnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Treace Medical Concepts, Inc of Class Action Lawsuit and Upcoming Deadlines - TMCI

April 30 at 10:30 AM | accessnewswire.com

June 10, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against TMCI

April 30 at 7:30 AM | accessnewswire.com

SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Treace Medical Concepts, Inc. (NASDAQ: TMCI)

April 30 at 7:15 AM | accessnewswire.com

TMCI STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Treace Medical Concepts, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

April 30 at 7:00 AM | accessnewswire.com

Treace Medical Concepts, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before June 10, 2025 to Discuss Your Rights - TMCI

April 29 at 7:30 PM | accessnewswire.com

ROSEN, A TOP RANKED LAW FIRM, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TMCI

April 29 at 7:08 PM | globenewswire.com

Treace Medical Concepts, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - TMCI

April 29 at 3:15 PM | accessnewswire.com

TMCI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Treace Medical Concepts, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

April 29 at 3:00 PM | accessnewswire.com

Contact Levi & Korsinsky by June 10, 2025 Deadline to Join Class Action Against Treace Medical Concepts, Inc. (TMCI)

April 29 at 1:10 PM | globenewswire.com

Treace Medical Concepts, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - TMCI

April 29 at 12:30 PM | accessnewswire.com

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Shares Acquired by Birchview Capital LP

April 28 at 6:53 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Why D-Wave's Project With Davidson Is a Game-Changer For Quantum
By Nathan Reiff | April 30, 2025
View Why D-Wave's Project With Davidson Is a Game-Changer For Quantum
Buffett’s $150B Bond Move: What It Really Means for Investors
By Gabriel Osorio-Mazilli | April 7, 2025
View Buffett’s $150B Bond Move: What It Really Means for Investors
AppLovin: Can Record Profits Overcome Market Skepticism?
By Jeffrey Neal Johnson | April 19, 2025
View AppLovin: Can Record Profits Overcome Market Skepticism?
Why Uber’s Stock Could Soar on AV Growth and Tariff Resilience
By Jea Yu | April 16, 2025
View Why Uber’s Stock Could Soar on AV Growth and Tariff Resilience
Occidental’s Hidden Gem: How OxyChem Could Boost Profits
By Jea Yu | April 29, 2025
View Occidental’s Hidden Gem: How OxyChem Could Boost Profits

PROF, KIDS, BBNX, and TMCI Company Descriptions

Beta Bionics NASDAQ:BBNX

$11.05 +0.06 (+0.55%)

As of 04:00 PM Eastern

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

OrthoPediatrics NASDAQ:KIDS

$20.82 -0.73 (-3.39%)

As of 04:00 PM Eastern

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Profound Medical NASDAQ:PROF

$4.99 +0.10 (+2.04%)

As of 04:00 PM Eastern

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.

Treace Medical Concepts NASDAQ:TMCI

$7.08 +0.03 (+0.43%)

As of 04:00 PM Eastern

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time